Scientists Hail Promise Of First Effective Ebola Treatments

Scientists Hail Promise Of First Effective Ebola Treatments

New Delhi: Scientists are now a step closer to find the first effective treatments for the deadly Ebola hemorrhagic fever after two potential drugs showed encouraging survival results in a clinical trial in Congo, Africa. 

Two experimental drugs — Regeneron’s REGN-EB3 and a monoclonal antibody called mAb114 — were both developed using antibodies harvested from survivors of Ebola infection.

The two experimental drugs showed “clearly better” results in patients in a trial of four potential treatments being conducted during the world’s second largest Ebola outbreak in history, now entering its second year in Democratic Republic of Congo.

The drugs improved survival rates from the disease more than two other treatments being tested — ZMapp, made by Mapp Biopharmaceutical, and Remdesivir, made by Gilead Sciences — and those products will be now dropped, said Anthony Fauci, one of the researchers co-leading the trial.

Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, told reporters in a telephone briefing the results were “very good news” for the fight against Ebola.

“What this means is that we do now have what look like (two) treatments for a disease for which not long ago we really had no approach at all,” he said.

Ebola has been spreading in eastern Congo since August 2018 in an outbreak that has now become the second largest, killing at least 1,800 people. Efforts to control it have been hampered by militia violence and some local resistance to outside help.

For More World News Click Here 

Support Our Credible Journalism By subscribing to dailyaddaa. For the latest news on dailyaddaa,  like us on  Facebook   and follow us on Twitte